Discover Tenders by New Activated Carbon Sector

Find the most relevant tenders for New Activated Carbon. Access the latest tender notices from various government and private organizations published across hundreds of websites and newspapers.Obtain complete and accurate information on New Activated Carbon tenders, including all tender documents, RFPs, RFQs,and more. Utilize our advanced filters to search for New Activated Carbon tenders by organization, tender value, opening and closing dates, and more.

Filter Your Search

Country

Sector

Region

Funding Agency

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Bempedoic Acid C10Ax15 Within The Framework Of A So Called Open House Model

Deadline: 31 May 2026

Germany

Ref. No.: 6227068

EMD:Ref Document

Bid Value: Ref Document

209 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Lisdexamfetamine N06Ba12 Within The Framework Of A So Called Open House Model

Deadline: 31 May 2026

Germany

Ref. No.: 6225281

EMD:Ref Document

Bid Value: Ref Document

209 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Etanercept L04Ab01 Within The Framework Of A So Called Open House Model

Deadline: 31 May 2026

Germany

Ref. No.: 6224846

EMD:Ref Document

Bid Value: Ref Document

209 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Ustekinumab L04Ac05 Within The Framework Of A So Called Open House Model

Deadline: 31 May 2026

Germany

Ref. No.: 6224416

EMD:Ref Document

Bid Value: Ref Document

209 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredients Bempedoic Acid And Ezetimibe C10Ba10 Within The Framework Of A So Called Open House

Deadline: 31 May 2026

Germany

Ref. No.: 6223493

EMD:Ref Document

Bid Value: Ref Document

209 Days Left

Conclusion Of Non Exclusive Discount Agreements According To Section 130A Paragraph 8 Sgb V Open House Model

Deadline: 01 Jun 2026

Germany

Ref. No.: 6223117

EMD:Ref Document

Bid Value: Ref Document

210 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Naloxegol A06Ah03 Within The Framework Of A So Called Open House Model

Deadline: 31 May 2026

Germany

Ref. No.: 6222391

EMD:Ref Document

Bid Value: Ref Document

209 Days Left

Dla Emergent Iv Research And Development Program

Deadline: 12 Jun 2027

United States

Ref. No.: 6205105

EMD:Ref Document

Bid Value: Ref Document

586 Days Left

Conclusion Of A Non Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient Lisdexamfetamine Atc Code N06Ba12

Deadline: 27 May 2026

Germany

Ref. No.: 6189945

EMD:Ref Document

Bid Value: Ref Document

205 Days Left

Conclusion Of A Non Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient Fusidic Acid Atc Code D06Ax01

Deadline: 27 May 2026

Germany

Ref. No.: 6189911

EMD:Ref Document

Bid Value: Ref Document

205 Days Left

Conclusion Of A Non Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient Combination Of Olodaterol And Tiotropium Bromide Atc Code R03Al06

Deadline: 27 May 2026

Germany

Ref. No.: 6184473

EMD:Ref Document

Bid Value: Ref Document

205 Days Left

Conclusion Of A Non Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient Trientine Atc Code A16Ax12

Deadline: 27 May 2026

Germany

Ref. No.: 6183142

EMD:Ref Document

Bid Value: Ref Document

205 Days Left

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For Drugs With The Trade Name Oralair Atc Code According To Who V01Aa02

Deadline: 31 Jul 2026

Germany

Ref. No.: 6175344

EMD:Ref Document

Bid Value: Ref Document

270 Days Left

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For The Active Ingredient Lipegfilgrastim Atc Code According To Who L03Aa14

Deadline: 30 Apr 2026

Germany

Ref. No.: 6174040

EMD:Ref Document

Bid Value: Ref Document

178 Days Left

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For Drugs With The Trade Name Orylmyte Atc Code According To Who V01Aa03

Deadline: 31 Jul 2026

Germany

Ref. No.: 6173952

EMD:Ref Document

Bid Value: Ref Document

270 Days Left

Showing 60031 to 60045 of 60688 results

‹
1
2
...
4000
4001
4002
4003
4004
4005
4006
...
4045
4046
›

Discover Tenders by New Activated Carbon Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by New Activated Carbon Sector

Filter Your Search

FREE Trial plan for all new users!